ArticleCureus2026
Morphea En Coup De Sabre Treated With Combination Hyaluronic Acid Filler and Neuromodulator: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Morphea en coup de sabre is a localized scleroderma variant that often leaves permanent, disfiguring frontoparietal atrophy after disease stabilization. We report a 27-year-old woman with four stable, linear, atrophic forehead plaques consistent with burned-out morphea en coup de sabre who sought cosmetic improvement. Targeted prabotulinumtoxin-A was administered to hyperfunctional temporalis, corrugator supercilii, and depressor supercilii muscles to reduce dynamic deforming forces. Two weeks later, hyaluronic acid filler was delivered via a blunt-tipped microcannula on the periosteal plane in a zonal pattern to restore contour. This combination approach provided immediate, natural-appearing correction maintained with small-volume retreatments every six to 12 months without complications. This case illustrates that neuromodulator and hyaluronic acid filler, delivered with a cannula, may offer a safe, minimally invasive option for aesthetic rehabilitation of burned-out morphea en coup de sabre by addressing muscle imbalance while reshaping and contouring the forehead.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.